Milich Krista M, Deimel Caroline, Schaebs Franka S, Thornburg Jonathan, Deschner Tobias, Vitzthum Virginia J
The Kinsey Institute for Research in Sex, Gender and Reproduction, Indiana University, Morrison Hall 313, 1165 East Third Street, Bloomington, IN, 47405, USA.
Horm Cancer. 2015 Aug;6(4):182-8. doi: 10.1007/s12672-015-0221-6. Epub 2015 Apr 17.
Some studies have reported that birth size is a risk factor for breast cancer, but the reasons for this observation are unknown. Ovarian hormone concentrations may be a link between birth size and breast cancer, but the few tests of this hypothesis are inconsistent, perhaps because of differences in sample composition, inclusion of anovulatory cycles, or use of one hormonal measurement per woman. We present results from the first study to use daily hormonal measurements throughout a woman's complete ovulatory cycle to test the hypothesized relationship between birth size and adult progesterone concentrations. We used a study sample and accompanying data set previously obtained for another research project in which we had collected daily urine samples from 63 healthy premenopausal women throughout a menstrual cycle. Multivariate regression was used to test for trends of individual progesterone indices (from 55 ovulatory cycles) with birth weight or ponderal index, while controlling for age, adult BMI, and age at menarche. Our main finding was that neither birth weight nor ponderal index was associated with biologically significant variation in luteal progesterone indices; the best-estimated effect sizes of birth size on these progesterone indices were small (3.7-10.2%). BMI was the only significant predictor of mean peak urinary progesterone, but it explained <6% of the variance. Our findings, in light of what is currently known regarding associations of breast cancer risk with birth size and adult size, suggest that environmental factors (particularly those that vary by socioeconomic status and affect growth) may underlie associations between birth size and cancer risks without there being any association of birth size with adult ovarian hormone concentrations.
一些研究报告称出生时的体型是乳腺癌的一个风险因素,但这一观察结果的原因尚不清楚。卵巢激素浓度可能是出生时的体型与乳腺癌之间的联系,但对这一假设的少数测试结果并不一致,可能是由于样本构成的差异、无排卵周期的纳入,或每位女性仅使用一次激素测量值。我们展示了第一项研究的结果,该研究在女性完整的排卵周期中进行每日激素测量,以检验出生时的体型与成年后孕酮浓度之间的假设关系。我们使用了一个研究样本及随附的数据集,这些是之前为另一个研究项目获取的,在该项目中,我们在一个月经周期内从63名健康的绝经前女性那里收集了每日尿液样本。在控制年龄、成年后体重指数和初潮年龄的同时,使用多变量回归来检验个体孕酮指标(来自55个排卵周期)与出生体重或 ponderal 指数之间的趋势。我们的主要发现是,出生体重和 ponderal 指数均与黄体期孕酮指标的生物学显著变化无关;出生时的体型对这些孕酮指标的最佳估计效应大小很小(3.7 - 10.2%)。体重指数是平均尿孕酮峰值的唯一显著预测因素,但它解释的方差不到6%。鉴于目前已知的乳腺癌风险与出生时的体型和成年体型之间的关联,我们的研究结果表明,环境因素(特别是那些因社会经济地位而异并影响生长的因素)可能是出生时的体型与癌症风险之间关联的基础,而出生时的体型与成年卵巢激素浓度之间不存在任何关联。